Local news: Los Angeles, CA  (change)

 | 

Join the Topix community today: 

Sign Up

 | 

Sign In

Advertisment
Wyeth

May 8, 2008

Biotech Stocks' Various Lupus Therapies: Opportunity or Lost Cause?

For a long time, few drugs were developed for rheumatological diseases. It was considered unattractive from a commercial viewpoint since relatively few patients suffered from them. via The Biotech Stock Blog

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Wyeth Discussions
Topic Updated Last By Comments
ativan untill 2003 Wyeth product May '08 patient 3
Wyeth's Pristiq, A New Treatment For Major Depr... May '08 sakara18235 1
Progenics, Wyeth constipation drug gets FDA app... Apr '08 SammyS 3
Wyeth And Progenics Provide Update On Phase 3 C... Mar '08 David 1
Big Pharma expected to dominate key cancer meeting (from Jun '06) Mar '08 Xiangjun 3
Wyeth to Invest $280 Million to Build State-of-... Mar '08 Xiangjun 1
Wyeth to Invest $280M in China Plant Mar '08 patient 1